LIMD2 and thyroid cancer: High levels of LIMD2 are detected in metastatic PTC and CRISPR/Cas9 gene editing of LIMD2 in thyroid cancer cell lines BCPAP and TPC1 reduced cell invasion and modified cell polarity [55].